|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-3.41/-0.74
|
企业价值
11.00M
|
资产负债 |
每股账面净值
1.68
|
现金流量 |
现金流量率
--
|
损益表 |
收益
310.00K
|
每股收益
0.00
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/21 21:18 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatmentand potentially enable fast-track therapeutic development in this patient population. |